Sign in

CIK 0001799191

  • Accelerated filer
  • Smaller reporting company

Starling Oncology, Inc.

Sign in to watch
Tickers
STLN STLNW DFPH
Exchange
Nasdaq, OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
843562323
Phone
+1 562-735-3226
Business address
18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
Former names
Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.

Securities

  • STLN Common Stock Nasdaq
  • STLNW Common stock Nasdaq
  • DFPH Common stock OTC
  1. 4/A Derivatives Options or other derivatives
  2. 4 Grant or award Chief Financial Officer acquired 32,092 shares (grant or award)
  3. 4 Grant or award Director acquired 23,191 shares (grant or award)
  4. 4 Grant or award Chief Executive Officer acquired 108,469 shares (grant or award)
  5. 4 Grant or award Director acquired 19,992 shares (grant or award)
  6. 4 Grant or award President acquired 42,015 shares (grant or award)
  7. 4 Grant or award Director acquired 20,792 shares (grant or award)
  8. 4 Grant or award Chief Medical Officer acquired 14,884 shares (grant or award)
  9. 4 Grant or award Chief Operating Officer acquired 28,027 shares (grant or award)
  10. 4 Grant or award Director acquired 45,905 shares (grant or award)
  11. 4 Grant or award Director acquired 22,391 shares (grant or award)
  12. 4 Grant or award Director acquired 20,792 shares (grant or award)
  13. 3/A Insider 3/A
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy Director bought 5,000 shares at an average $6.92 ($34,605)
  17. 4 Open-market buy Director bought 5,000 shares at an average $6.34 ($31,699)
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 4/A Grant or award Director acquired 4,109,771 shares (grant or award)

Page 12 of 14 · 270 filings